AAPL vs. JNJ: Apple vs. Johnson & Johnson Stock Comparison
How do Apple (AAPL) and Johnson & Johnson (JNJ) stack up? This page sets them side by side across company profile, performance and risk, profitability, growth, financial strength, dividends, and valuation, with selected fundamentals also measured against each stock's industry-group peers.
Company Profile
Apple (AAPL) is classified in the Information Technology sector (Technology Hardware & Equipment), whereas Johnson & Johnson (JNJ) belongs to Health Care (Pharmaceuticals, Biotechnology & Life Sciences) — their GICS classifications point to very different parts of the market.
| Profile Item | AAPL | JNJ |
|---|---|---|
| Name | Apple Inc. | Johnson & Johnson |
| Country/Region | United States | United States |
| GICS Sector | Information Technology | Health Care |
| GICS Industry Group | Technology Hardware & Equipment | Pharmaceuticals, Biotechnology & Life Sciences |
| GICS Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| GICS Sub-Industry | Technology Hardware, Storage & Peripherals | Pharmaceuticals |
| Market Capitalization | 4,167.98 billion USD | 613.02 billion USD |
| Currency | USD | USD |
| Exchange | Nasdaq | NYSE |
| Listing Date | December 12, 1980 | January 2, 1962 |
| Security Type | Common Stock | Common Stock |
Price Performance
Cumulative Growth
Trailing Returns
Performance Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Total Return (1Y) | 41.74% | 71.71% |
Risk Profile
Drawdown History
Risk Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Volatility (1Y, Annualized) | 23.65% | 17.88% |
| Beta (5Y) | 1.11 | 0.22 |
| Avg. Volume (3M) | 52.14M | 8.03M |
Risk-Adjusted Performance
Risk-Return Positioning
Profitability
ROE (TTM)
Both companies show strong equity returns, but Apple (AAPL) at 141.47% is the standout with ROE above its industry range; Johnson & Johnson (JNJ) at 26.42% also sits in the top quartile.
AAPL
Technology Hardware & Equipment industry group
141.47%
- AAPL
- 141.47%
- Max
- 44.16%
- Q3
- 19.42%
- Median
- 10.99%
- Q1
- 1.30%
- Min
- -25.17%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
26.42%
- Max
- 94.73%
- JNJ
- 26.42%
- Q3
- 2.50%
- Median
- -31.88%
- Q1
- -61.60%
- Min
- -157.07%
Net Margin (TTM)
Johnson & Johnson (JNJ) at 21.83% keeps the most of each sales dollar — above its industry’s net margin range — and Apple (AAPL) at 27.15% also retains a top-quartile share.
AAPL
Technology Hardware & Equipment industry group
27.15%
- Max
- 30.43%
- AAPL
- 27.15%
- Q3
- 12.35%
- Median
- 4.70%
- Q1
- 0.00%
- Min
- -14.09%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
21.83%
- JNJ
- 21.83%
- Max
- 11.93%
- Q3
- 2.91%
- Median
- 0.00%
- Q1
- -3.26%
- Min
- -11.53%
Operating Margin (TTM)
Both Apple (AAPL) at 32.28% and Johnson & Johnson (JNJ) at 27.41% convert sales into operating profit at a top-quartile rate, pointing to tighter cost discipline before financing and tax.
AAPL
Technology Hardware & Equipment industry group
32.28%
- AAPL
- 32.28%
- Max
- 32.28%
- Q3
- 15.32%
- Median
- 6.62%
- Q1
- 1.88%
- Min
- -18.24%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
27.41%
- Max
- 100.30%
- JNJ
- 27.41%
- Q3
- 4.58%
- Median
- 0.00%
- Q1
- -132.35%
- Min
- -332.88%
Profitability Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| ROE (TTM) | 141.47% | 26.42% |
| ROA (TTM) | 26.23% | 8.42% |
| Net Margin (TTM) | 27.15% | 21.83% |
| Operating Margin (TTM) | 32.28% | 27.41% |
| Gross Margin (TTM) | 47.86% | 68.04% |
Growth
Revenue Growth
Revenue Growth Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Revenue Growth (YoY) | 6.43% | 6.05% |
| Revenue Growth (3Y CAGR) | 1.81% | 5.60% |
EPS Growth
EPS Growth Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| EPS Growth (YoY) | 22.70% | 90.50% |
| EPS Growth (3Y CAGR) | 6.88% | 17.90% |
Financial Strength
Current Ratio (MRQ)
Both Apple (AAPL) at 1.07 and Johnson & Johnson (JNJ) at 1.03 run current ratio in the tighter-liquidity quartile of industry peers, leaving thinner cushions against current liabilities than typical competitors.
AAPL
Technology Hardware & Equipment industry group
1.07
- Max
- 5.80
- Q3
- 3.18
- Median
- 1.90
- Q1
- 1.28
- AAPL
- 1.07
- Min
- 0.51
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
1.03
- Max
- 26.16
- Q3
- 12.31
- Median
- 5.55
- Q1
- 2.67
- JNJ
- 1.03
- Min
- 0.23
Debt / Equity (MRQ)
Both Apple (AAPL) at 0.80 and Johnson & Johnson (JNJ) at 0.68 fund their balance sheets with roughly industry-typical debt-to-equity mixes.
AAPL
Technology Hardware & Equipment industry group
0.80
- Max
- 2.02
- Q3
- 0.89
- AAPL
- 0.80
- Median
- 0.31
- Q1
- 0.06
- Min
- 0.00
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
0.68
- Max
- 1.60
- Q3
- 0.69
- JNJ
- 0.68
- Median
- 0.15
- Q1
- 0.02
- Min
- 0.00
Financial Strength Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Current Ratio (MRQ) | 1.07 | 1.03 |
| Debt / Equity (MRQ) | 0.80 | 0.68 |
| Net Debt / EBITDA | 0.10 | 0.96 |
Dividends
Dividend Yield (TTM)
Apple (AAPL) at 0.38% earns its spot in the top quartile of its industry’s yields; Johnson & Johnson (JNJ) at 2.12% is past the top of its own peer range — territory where a dividend-safety check matters more than the headline number.
AAPL
Technology Hardware & Equipment industry group
0.38%
- Max
- 0.70%
- AAPL
- 0.38%
- Q3
- 0.33%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
2.12%
- JNJ
- 2.12%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Payout Ratio (TTM)
Apple (AAPL) at 12.59% keeps its payout in the industry’s typical band, while Johnson & Johnson (JNJ) at 60.25% pays out more than any of its peers — the most stretched cover in its group.
AAPL
Technology Hardware & Equipment industry group
12.59%
- Max
- 36.36%
- Q3
- 14.56%
- AAPL
- 12.59%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
60.25%
- JNJ
- 60.25%
- Max
- 0.00%
- Q3
- 0.00%
- Median
- 0.00%
- Q1
- 0.00%
- Min
- 0.00%
Dividend Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| Dividend Yield (TTM) | 0.38% | 2.12% |
| Dividend Payout Ratio (TTM) | 12.59% | 60.25% |
Valuation
P/E Ratio (TTM)
Both Apple (AAPL) at 34.36 and Johnson & Johnson (JNJ) at 29.51 land around their industries’ usual P/E ratio levels — neither is getting a clear earnings-multiple discount or premium versus peers.
AAPL
Technology Hardware & Equipment industry group
34.36
- Max
- 158.77
- Q3
- 79.26
- Median
- 37.06
- AAPL
- 34.36
- Q1
- 22.04
- Min
- 8.47
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
29.51
- Max
- 84.64
- Q3
- 47.76
- JNJ
- 29.51
- Median
- 26.11
- Q1
- 15.68
- Min
- 2.01
P/S Ratio (TTM)
Johnson & Johnson (JNJ) at 6.36 is priced about in line with its industry on P/S ratio, while Apple (AAPL) at 9.23 sits in the pricier quartile — AAPL costs more per dollar of sales.
AAPL
Technology Hardware & Equipment industry group
9.23
- Max
- 18.49
- AAPL
- 9.23
- Q3
- 8.40
- Median
- 3.72
- Q1
- 1.43
- Min
- 0.00
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
6.36
- Max
- 63.43
- Q3
- 27.40
- Median
- 7.60
- JNJ
- 6.36
- Q1
- 3.32
- Min
- 0.01
P/B Ratio (MRQ)
Both look rich against book: Johnson & Johnson (JNJ) at 7.55 sits in the upper P/B ratio quartile, and Apple (AAPL) at 39.09 prices even higher, above its industry range.
AAPL
Technology Hardware & Equipment industry group
39.09
- AAPL
- 39.09
- Max
- 18.50
- Q3
- 8.94
- Median
- 4.37
- Q1
- 2.16
- Min
- -3.51
JNJ
Pharmaceuticals, Biotechnology & Life Sciences industry group
7.55
- Max
- 15.47
- JNJ
- 7.55
- Q3
- 7.43
- Median
- 3.88
- Q1
- 1.83
- Min
- -6.23
Valuation Metrics
| Metric | AAPL | JNJ |
|---|---|---|
| P/E Ratio (TTM) | 34.36 | 29.51 |
| P/S Ratio (TTM) | 9.23 | 6.36 |
| P/B Ratio (MRQ) | 39.09 | 7.55 |
| Free Cash Flow Yield (TTM) | 2.43% | 2.04% |